Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Income Statement [Abstract]
Net revenues	$ 11,713,055	$ 8,497,701
Costs and expenses:
Cost of products sold	1,425,714	1,575,542
Selling and marketing	4,231,980	4,154,588
Research and development	1,295,076	1,158,253
General and administrative	2,463,008	2,367,907
Amortization	1,005,330	1,110,661
Total costs and expenses	10,421,108	10,366,951
Operating income (loss)	1,291,947	(1,869,250)
Interest income	125,709	96,746
Interest expense	(163,802)	(118,526)
Income (loss) before income taxes	1,253,854	(1,891,030)
Income tax expense	(5,670)	(11,442)
Net income (loss)	1,248,184	(1,902,472)
Net loss (income) at subsidiary attributable to noncontrolling interests	8,884	(43,791)
Net income (loss) attributable to common shareholders	$ 1,257,068	$ (1,946,263)
Earnings (loss) per share attributable to common shareholders
Basic (in USD per share)	$ 0.08	$ (0.14)
Diluted (in USD per share)	$ 0.08	$ (0.14)
Weighted-average shares outstanding
Basic (in shares)	14,942,522	14,098,022
Diluted (in shares)	15,259,824	14,098,022